To advance cancer screening technologies and methodologies to reduce cancer-related illnesses and deaths
The goal of cancer screening is to reduce the burden of cancer by finding cancers at an early stage when the chance of cure is highest. Cancer screenings have been used for decades, but a new generation of multi-cancer detection (MCD) blood tests could improve early detection.
The Vanguard Study strives to understand how well two multi-cancer detection blood tests perform as cancer screening tests. We are seeking adults who are:
- 45-75 years old;
- Do not have any diagnoses in the last 5 years;
- Are not currently undergoing a work-up for possible cancer; and
- Are not pregnant and do not intend to become pregnant within 1 year.
The Vanguard Study is the first study being done by the new Cancer Screening Research Network (CSRN). CSRN is a national clinical trials network created by the National Cancer Institute (NCI) to study new technologies for cancer screening.
Why Join Our Study?
“Be a part of important research that can help improve access to cancer screening”
We are inviting adults who are eligible for cancer screening from around the country to be a part of the Vanguard Study within the Cancer Screening Research Network (CSRN).
This research study involves questionnaires, blood draws, and a review of medical records for information related to the study during the two-year time you participate.
In addition to helping to advance research for cancer screening, some participants may receive results from a multi-cancer detection blood test.
- Complete 3 questionnaires over a two-year period
- Complete 2 blood draws over a two-year period
- Allow study researchers to review your relevant medical history, health records, and results of cancer-related testing over a two-year period
- Be a part of important research to help learn more about cancer screening.
- Possibility of getting results of multi-cancer detection blood tests if you are randomly assigned to one of the groups who will be given these tests.
- No cost to participate.
How do I join the Vanguard Study?
Email: sitemancsrn_vanguard@wustl.edu
Phone: 314.362.5539